Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
(ODYSSEY RCC Trial)
Recruiting in Palo Alto (17 mi)
+10 other locations
DG
Overseen byDaniel George, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Duke University
No Placebo Group
Trial Summary
What is the purpose of this trial?
ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.
Research Team
DG
Daniel George, MD
Principal Investigator
Duke University
Eligibility Criteria
Inclusion Criteria
Age 19 or over at time of informed consent.
Diagnosis of metastatic renal cell cancer (mRCC) with less than 6 weeks of first-line systemic therapy for mRCC.
Prior surgery and radiation therapy are permitted.
See 4 more
Treatment Details
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Duke UniversityDurham, NC
The Regents of the University of MichiganAnn Arbor, MI
University of PittsburghPittsburgh, PA
University of Kansas Medical CenterKansas City, KS
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Trials
2495
Patients Recruited
5,912,000+
Duke Clinical Research Institute
Collaborator
Trials
69
Patients Recruited
242,000+
Bristol-Myers Squibb
Industry Sponsor
Trials
2731
Patients Recruited
4,127,000+
Headquarters
New York City, USA
Known For
Oncology & Cardiovascular
Top Products
Eliquis, Opdivo, Revlimid, Orencia
Exelixis
Industry Sponsor
Trials
126
Patients Recruited
20,500+
Merck Sharp & Dohme LLC
Industry Sponsor
Trials
4096
Patients Recruited
5,232,000+
Pfizer
Industry Sponsor
Trials
4712
Patients Recruited
50,980,000+
Known For
Vaccine Innovations
Top Products
Viagra, Zoloft, Lipitor, Prevnar 13